Company / Net Income
Centessa Pharmaceuticals plc Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$197.5M
FY2025
5-year range
-$381.1M / -$151.1M
FY2021-FY2025
Trend
+16.2%
vs FY2024
Sector context
#155 of 216
Health Care
What the data says
At -$198M, Centessa Pharmaceuticals plc's net income ranks #155 of 216 in the Health Care sector. Net Income has fluctuated over the past 7 years, ranging from -$381M in FY2021 to -$5M in FY2019.
Based on SEC 10-K filings.
-$198M in FY2025.
Declined from -$151M to -$198M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#155 of 216 in Health CareTop 72% of 216This company -$197.5M Sector average $454.3M
▼
-143.5% below sector average
Key checks
Key Insights
- In FY2025, net income increased 16.2% year-over-year.
- Ranks #155 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2019.
- Lowest net income in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$197.5M | +16.2% |
| FY2024 | -$235.8M | -56.0% |
| FY2023 | -$151.1M | +30.1% |
| FY2022 | -$216.2M | +43.3% |
| FY2021 | -$381.1M | -3473.8% |
| FY2020 | -$10.7M | -110.7% |
| FY2019 | -$5.1M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026